Published in
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., 2021
Links
Tools
First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743
Journal article published in 2021 by
H. Bischoff,
A. Scherpereel,
S. Antonia,
Y. Bautista,
F. Grossi,
D. Kowalski,
G. Zalcman 
,
A. Nowak,
N. Fujimoto,
S. Peters,
A. Tsao,
A. Mansfield,
S. Popat,
X. Sun,
B. Padilla
and other authors.
,
A. Nowak,
N. Fujimoto,
S. Peters,
A. Tsao,
A. Mansfield,
S. Popat,
X. Sun,
B. Padilla
and other authors.
